Help


SMS Terms & Conditions: By agreeing to these EFFEXOR XR Rx Mobile Program (“Program”) text message Terms and Conditions, you agree to receive text messages on your mobile device subject to the terms & conditions described below. You also consent to receive autodialed and/or pre-recorded calls and/or text messages from or on behalf of EFFEXOR XR at the telephone number provided above. I understand that this consent is not a condition of purchase or use of EFFEXOR XR or of any Pfizer product or service.
  • Participants will receive an average of 1-3 text messages each month while enrolled in the Program. Texts will be delivered based on each participant’s pharmacy refill cycle
  • There is no fee payable to Pfizer to receive text messages; however, your carrier’s message and data rates may apply
  • Data obtained from you in connection with your registration for, and use of, this SMS service may include your phone number and/or email address, related carrier information, and elements of pharmacy claim information and will be used to administer this program and to provide program benefits such as information about your prescription, refill reminders, as well as program updates and alerts
  • Pfizer will not be liable for any delays in the receipt of any SMS messages as delivery is subject to effective transmission from your network operator
  • This program is valid with most major US carriers, including: The service available on these US carriers only: Verizon Wireless, Sprint, Nextel, Boost, T-Mobile®, AT&T, Alltel, ACS Wireless, Bluegrass Cellular, Carolina West Wireless, CellCom, Cellular One of East Central Illinois (ECIT), Cincinnati Bell, Cricket, C-Spire Wireless, Duet IP (AKA Max/Benton/Albany), Element Mobile, Epic Touch, GCI Communications, Golden State, Hawkeye (Chat Mobility), Hawkeye (NW Missouri Cellular), Illinois Valley Cellular (IVC), Inland Cellular, iWireless, Keystone Wireless (Immix/PC Management), MetroPCS, MobiPCS, Mosaic, MTPCS/Cellular One (Cellone Nation), Nex-Tech Wireless, nTelos, Panhandle Telecommunications, Pioneer, Plateau, Revol Wireless, Rina-Custer, Rina-All West, Rina-Cambridge Telecom Coop, Rina-Eagle Valley Comm, Rina-Farmers Mutual Telephone Co, Rina-Nucla Nutria Telephone Co, Rina-Silver Star, Rina-South Central Comm, Rina-Syringa, Rina-UBET, Rina-Manti, Simmetry, South Canaan/CellularOne of NEPA, Thumb Cellular, Union Wireless, United Wireless, U.S. Cellular, Viaero Wireless, Virgin Mobile, West Central Wireless (includes Five Star Wireless)
  • Pfizer reserves the right to rescind, revoke or amend the EFFEXOR XR Rx Mobile Program without notice at any time
  • You can unsubscribe from the program by texting STOP.  For questions about this program, text HELP or contact the customer support center at 1-800-725-4125

Pay as little as $4 per month for brand-name EFFEXOR XR*

*Terms and conditions apply.You may pay less by receiving the generic.

EFFEXOR XR is available in different dosage strengths (37.5 mg, 75 mg, and 150 mg).

Important Safety Information and Indications

Suicidality and Antidepressant Drugs

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Effexor XR is not approved for use in children and teens.

Do not take EFFEXOR XR if you:

  • Are allergic to Effexor XR or any of the ingredients in Effexor XR
  • Have uncontrolled angle-closure glaucoma
  • Currently take, or have taken within the last 14 days, any medicine known as an MAOI such as linezolid or methylene blue. Do not take an MAOI within 7 days of stopping Effexor XR. Ask your doctor or pharmacist if you are not sure if your medicine is an MAOI

All patients taking antidepressants should be watched closely for signs that their condition is getting worse or that they are becoming suicidal, especially when they first start therapy, or when their dose is increased or decreased. Patients should also be watched for becoming agitated, irritable, hostile, aggressive, impulsive, or restless. Such symptoms should be reported to the patient's doctor right away.

Before taking Effexor XR, tell your doctor and pharmacist about all prescription and over-the-counter medications and supplements you take or plan to take including: those to treat migraines or psychiatric disorders (including other antidepressants or amphetamines) to avoid a potentially life-threatening condition called serotonin syndrome.

Effexor XR may raise blood pressure in some patients. Your blood pressure should be controlled before starting treatment and should be monitored regularly.

Taking Effexor XR with aspirin, nonsteroidal anti-inflammatory drugs, warfarin, or other blood thinners may increase the risk of bleeding events.

Some people are at risk for visual problems such as eye pain, changes in vision, or swelling or redness around the eye. You may want to undergo an eye examination to see if you are at risk and get preventative treatment if you are.

When people suddenly stop using or quickly lower their daily dose of Effexor XR, serious discontinuation symptoms may occur. Talk to your doctor before discontinuing or reducing your dose of Effexor XR.

Pregnant or nursing women shouldn't take any antidepressant without consulting their doctor.

Until you see how Effexor XR affects you, be careful doing such activities as driving a car or operating machinery. Avoid drinking alcohol while taking Effexor XR.

In clinical studies, the most common side effects with Effexor XR (reported in at least 5% of patients and at least twice as often as with placebo) were constipation, dizziness, dry mouth, insomnia, loss of appetite, nausea, nervousness, sexual side effects, sleepiness, sweating, and weakness.

Indications

Effexor XR extended-release capsules are a prescription medicine indicated for the treatment, in adults, of Depression, Generalized Anxiety Disorder (GAD), Social Anxiety Disorder (SAD), and Panic Disorder (PD) with or without agoraphobia.

Please see Full Prescribing Information, including BOXED WARNING, and Medication Guide for EFFEXOR XR.

Patients should always ask their doctors for medical advice about adverse events.

You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (US only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where health care professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch or call 1-800-FDA-1088.